Heparin
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
ME TherapeuticsNEW YORK, NY
2 programsSodium Heparin UQ subcutaneous drug administrationPHASE_11 trial
Sodium heparin UQ Intravenous drug administrationPHASE_11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
ME TherapeuticsSodium Heparin UQ subcutaneous drug administration
ME TherapeuticsSodium heparin UQ Intravenous drug administration
Clinical Trials (2)
Study With Heparin Sodium in Subcutaneous Administration
Start: Aug 2022Est. completion: Oct 2023
Phase 1Suspended
Study With Heparin Sodium in Intravenous Administration
Start: Feb 2021Est. completion: Nov 2022
Phase 1Suspended
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.